Insulin pump therapy with and without continuous glucose monitoring in pregnant women with type 1 diabetes: a prospective observational Orchestra Foundation study in Poland

被引:4
|
作者
Cypryk, Katarzyna [1 ]
Wender-Ozegowska, Ewa [2 ]
Cyganek, Katarzyna [3 ,4 ]
Sieradzki, Jacek [4 ]
Skoczylas, Kinga [5 ]
Chen, Xiaoxiao [6 ]
Cordero, Toni L. L. [6 ]
Shin, John [6 ]
Cohen, Ohad [7 ]
机构
[1] Med Univ Lodz, Dept Internal Dis & Diabetol, Pomorska Str 251, PL-92213 Lodz, Poland
[2] Poznan Univ Med Sci, Dept Reprod, Poznan, Poland
[3] Univ Hosp Krakow, Dept Metab Dis, Krakow, Poland
[4] Jagiellonian Univ Krakow, Coll Med, Krakow, Poland
[5] Medtronic, Warsaw, Poland
[6] Medtronic, Northridge, CA USA
[7] Medtronic, Tolochenaz, Switzerland
关键词
Type 1 diabetes-complicated pregnancy; HbA1c; Continuous subcutaneous insulin infusion (CSII); Continuous glucose monitoring (CGM); Large for gestational age (LGA); Neonatal outcomes; GLYCEMIC CONTROL; SEVERE HYPOGLYCEMIA; OUTCOMES; INFUSION; RISK; MELLITUS; IMPLEMENTATION; KETOACIDOSIS; PREECLAMPSIA; ASSOCIATION;
D O I
10.1007/s00592-022-02020-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsThe effects of continuous subcutaneous insulin infusion (CSII) therapy with or without continuous glucose monitoring (CGM) on neonatal outcomes and glycemic outcomes of pregnant women with type 1 diabetes (T1D), living in Poland, were assessed.MethodsThis prospective observational study enrolled women with T1D (N = 481, aged 18-45 years) who were pregnant or planned pregnancy. All used CSII therapy and a subset used CGM with CSII (CSII + CGM). Neonatal outcomes (e.g., rate of large for gestational age [LGA] delivery [birth weight > 90th percentile]) and maternal glycemia (e.g., HbA1c and percentage of time at sensor glucose ranges) were evaluated.ResultsOverall HbA1c at trimesters 1, 2, and 3 was 6.8 +/- 1.1% (50.9 +/- 12.3 mmol/mol, N = 354), 5.8 +/- 0.7% (40.1 +/- 8.0 mmol/mol, N = 318), and 5.9 +/- 0.7% (41.4 +/- 8.0 mmol/mol, N = 255), respectively. A HbA1c target of < 6.0% (42 mmol/mol) at each trimester was achieved by 20.9% (74/354), 65.1% (207/318), and 58.0% (148/255), respectively. For women using CSII + CGM versus CSII only, HbA1c levels at trimesters 1, 2, and 3 were 6.5 +/- 0.9% versus 7.1 +/- 1.3% (47.8 +/- 9.7 mmol/mol versus 54.3 +/- 14.0 mmol/mol, p < 0.0001), 5.7 +/- 0.6% versus 6.0 +/- 0.9% (38.9 +/- 6.5 mmol/mol versus 41.6 +/- 9.3 mmol/mol, p = 0.0122), and 5.8 +/- 0.6% versus 6.1 +/- 0.8% (40.3 +/- 6.9 mmol/mol versus 42.9 +/- 9.1 mmol/mol, p = 0.0117), respectively. For the overall, CSII only, and CSII + CGM groups, rates of LGA delivery were 22.7% (74/326), 24.6% (34/138), and 21.3% (40/188), respectively.ConclusionsObservational assessment of women with T1D using CSII therapy demonstrated low HbA1c throughout pregnancy and low rates of LGA. The addition of CGM to CSII therapy compared to CSII therapy alone was associated with some improved maternal glycemic and neonatal outcomes.Clinicaltrials.gov identifierNCT01779141 (January 2013).
引用
收藏
页码:553 / 561
页数:9
相关论文
共 50 条
  • [31] Effects of continuous glucose monitoring on glycaemic control in subjects with type 1 diabetes delivering insulin via pump or multiple daily injections: a prospective study
    Gottlieb, P. A.
    Crew, L. B.
    Moser, E. G.
    Voelmle, M. K.
    Beatson, C. R.
    Gutin, R. S.
    Garg, S. K.
    DIABETOLOGIA, 2010, 53 : S25 - S25
  • [32] The Study to Estimate the Long-Acting Effect of Insulin Degludec in Type 1 Diabetes: Using a Continuous Glucose Monitoring and Insulin Pump
    Hashimura, Kayako
    Kawamura, Tomoyuki
    Hotta, Yuko
    Hatano, Megumi
    Kashihara, Yoneo
    Hashimoto, Tomomi
    Hirose, Masakazu
    Higashide, Takashi
    Aono, Mayumi
    Aono, Shigeo
    Shintaku, Haruo
    DIABETES, 2015, 64 : A265 - A265
  • [33] Eating habits and sleep quality in individuals with type 1 diabetes on continuous glucose monitoring and insulin pump
    Corrado, Alessandra
    Scida, Giuseppe
    Vitale, Marilena
    Caprio, Benedetta
    Costabile, Giuseppina
    Annuzzi, Eric
    Della Pepa, Giuseppe
    Lupoli, Roberta
    Bozzetto, Lutgarda
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2024, 34 (07) : 1703 - 1711
  • [34] THE DAILY NEED FOR INSULIN IN PREGNANT WOMEN WITH TYPE 1 DIABETES, RECEIVING INSULIN WITH INSULIN PUMP
    Valeeva, F.
    Sharipova, J.
    Alimetova, Z.
    Gaysina, L.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A114 - A114
  • [35] Characterising frailty, metrics of continuous glucose monitoring, and mortality hazards in older adults with type 2 diabetes on insulin therapy (HARE): a prospective, observational cohort study
    Fung, Erik
    Lui, Leong-Ting
    Huang, Lei
    Cheng, King Fai
    Lau, Gloria H. W.
    Chung, Yi Ting
    Ahmadabadi, Behzad Nasiri
    Xie, Suyi
    Lee, Jenny S. W.
    Hui, Elsie
    So, Wing Yee
    Sung, Joseph J. Y.
    King, Irwin
    Goggins, William B.
    Chan, Queenie
    Jarvelin, Marjo-Riitta
    Ma, Ronald C. W.
    Chow, Elaine
    Kwok, Timothy
    LANCET HEALTHY LONGEVITY, 2021, 2 (11): : E724 - E735
  • [36] A Study of the Carbohydrate-to-Insulin Ratio in Pregnant Women with Type 1 Diabetes on Pump Treatment
    Bongiovanni, Marzia
    Fresa, Raffaella
    Visalli, Natalia
    Bitterman, Olimpia
    Suraci, Concetta
    Napoli, Angela
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 (06) : 360 - 365
  • [37] Continuous Glucose Monitoring in Pregnant Women with Type-1-Diabetes mellitus - Presentation of CONCEPTT-Study and Commentary
    Kleinwechter, Helmut
    DIABETOLOGIE UND STOFFWECHSEL, 2018, 13 (01) : 32 - 34
  • [38] Advantages of sensor-augmented insulin pump therapy for pregnant women with type?1 diabetes mellitus
    Imafuku, Hitomi
    Tanimura, Kenji
    Masuko, Naohisa
    Tomimoto, Masako
    Shi, Yutoku
    Uchida, Akiko
    Deguchi, Masashi
    Fujioka, Kazumichi
    Yamamoto, Akane
    Yoshino, Kei
    Hirota, Yushi
    Ogawa, Wataru
    Terai, Yoshito
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (12) : 1383 - 1390
  • [39] Insulin pump therapy in young children with type 1 diabetes: Results of the polish prospective pump study
    Pankowska, Ewa
    Szypowska, Agnieszka
    Szalecki, Mieczysiaw
    Surdej, Barbara
    Lisowicz, Lucyna
    Czerniawska, Elzbieta
    Mlynarski, Wojciech
    Florys, Bozena
    Kolender, Elzbieta
    DIABETES, 2007, 56 : A125 - A125
  • [40] Continuous glucose monitoring in pregnant women with type 1 diabetes (vol 390, pg 2327, 2017)
    Garg, S. K.
    Polsky, S.
    LANCET, 2017, 390 (10110): : 2346 - 2346